Of note, there’s emerging evidence suggesting a synergy between CSF1R signaling and the JAK/STAT3 axis, whereby their coordinated action bolsters the immunosuppressive capacities of MDSCs, further driving tumor immune evasion [6, 17, 18]. The gene discussed is CSF1R; the disease is neoplasm.